Cathy Mendelsohn

15PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersBiomaterialsCancer geneticsSurface water quality processes and contaminated sediment assessmentMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 10, 2026
Epithelial to mesenchymal transition and M2 macrophages drive aggressiveness in murine and human sarcomatoid urothelial carcinoma.

|Jul 22, 2026
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models.

|Sep 25, 2025
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer.

Sangkyou Lee, Sung Yun Jung, Pawel Kuś

|Sep 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies.

Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess

|Nov 18, 2024
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy.

Mathieu Rouanne, Noah Chen, Dylan L Mariuzza

|Sep 27, 2024
Nur77 protects the bladder urothelium from intracellular bacterial infection.

Christina A Collins, Chevaughn Waller, Ekaterina Batourina

Pageof 3

Frequent Collaborators

3 joint publications

Chao Lu

2 joint publications

Miguel Verbitsky

2 joint publications

David A Fasel

2 joint publications

Matthew G Sampson